Overview
Jeffrey Smerage is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Smerage is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Smerage is currently accepting new patients.
His clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Regents Of The University Of Michigan
John Krauss is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Krauss is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Anal Cancer. Dr. Krauss is currently accepting new patients.
Mercy Health Physicians North Specialty Care LLC
Adnan Al-Khalili is an Oncologist and a Hematologist in Perrysburg, Ohio. Dr. Al-Khalili is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Paget Disease of the Breast, Angiosarcoma, and Bone Marrow Aspiration. Dr. Al-Khalili is currently accepting new patients.
Oakland Medical Group - Division Of Clinical Hematology & Medical Oncology - Royal Oak
Maryann Shango is a Hematologist and an Oncologist in Royal Oak, Michigan. Dr. Shango has been practicing medicine for over 15 years and is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are HER-2 Positive Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Pseudomyxoma Peritonei. Dr. Shango is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Smerage isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Smerage isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Smerage isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Smerage isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- BRCA Positive Breast CancerDr. Smerage isAdvanced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Smerage isAdvanced. Learn about Breast Cancer in Men.
- HER-2 Positive Breast CancerDr. Smerage isAdvanced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Smerage isAdvanced. Learn about HER2 Negative Breast Cancer.
- Metastatic Pleural TumorDr. Smerage isAdvanced. Learn about Metastatic Pleural Tumor.
- Pseudomyxoma PeritoneiDr. Smerage isAdvanced. Learn about Pseudomyxoma Peritonei.
- Experienced
- Adrenal CancerDr. Smerage isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Smerage isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Smerage isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Smerage isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Smerage isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Smerage isExperienced. Learn about Alveolar Soft Part Sarcoma.